THE BEST SIDE OF LUMACAFTOR

CRC has an immunosuppressive TME which stops the event of a powerful response to ICB therapies. There is certainly thus an urgent have to establish the approaches reprogram this suppressive TME as a way to increase immunotherapy efficacy. In the current analyze, we applied CRISPR KO screens to discover genes that sensitize CRC to antitumor immunity